Search - tctmd.com

Displaying 1 - 20 of 64

Sort: Relevancy | Date

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Industry News

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

September 17, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Industry News

MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission

May 16, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

News Industry News

Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes

March 23, 2018

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Industry News

HeartStitch® Launches German Sales of NobleStitch™ EL

May 02, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Industry News

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

February 21, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

February 18, 2016

News Industry News

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

January 21, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Industry News

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

December 01, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

Advertisement

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

HeartStitch® Launches German Sales of NobleStitch™ EL

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content